BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 15816645)

  • 1. Differential cyclooxygenase-2 enzyme expression in radiosensitive versus radioresistant glioblastoma multiforme cell lines.
    Karim A; McCarthy K; Jawahar A; Smith D; Willis B; Nanda A
    Anticancer Res; 2005; 25(1B):675-9. PubMed ID: 15816645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of cyclooxygenase 2 (COX-2) in human glioma and in vitro inhibition by a specific COX-2 inhibitor, NS-398.
    Joki T; Heese O; Nikas DC; Bello L; Zhang J; Kraeft SK; Seyfried NT; Abe T; Chen LB; Carroll RS; Black PM
    Cancer Res; 2000 Sep; 60(17):4926-31. PubMed ID: 10987308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of intrinsic tumor cell radiosensitivity induced by a selective cyclooxygenase-2 inhibitor.
    Petersen C; Petersen S; Milas L; Lang FF; Tofilon PJ
    Clin Cancer Res; 2000 Jun; 6(6):2513-20. PubMed ID: 10873107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of poor survival by cyclooxygenase-2 in patients with T4 nasopharyngeal cancer treated by radiation therapy: clinical and in vitro studies.
    Chen WC; McBride WH; Chen SM; Lee KF; Hwang TZ; Jung SM; Shau H; Liao SK; Hong JH; Chen MF
    Head Neck; 2005 Jun; 27(6):503-12. PubMed ID: 15772955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of glioblastoma radioresponse by a selective COX-2 inhibitor celecoxib: inhibition of tumor angiogenesis with extensive tumor necrosis.
    Kang KB; Wang TT; Woon CT; Cheah ES; Moore XL; Zhu C; Wong MC
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):888-96. PubMed ID: 17293239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclooxygenase-2 expression in brain metastases.
    Karim A; Fowler M; Jones L; Patwardhan R; Vannemreddy P; Mccarthy K; Nanda A
    Anticancer Res; 2005; 25(4):2969-71. PubMed ID: 16080553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of cyclooxygenase-2 in uterine endometrial cancer and anti-tumor effects of a selective COX-2 inhibitor.
    Hasegawa K; Ohashi Y; Ishikawa K; Yasue A; Kato R; Achiwa Y; Nishio E; Udagawa Y
    Int J Oncol; 2005 May; 26(5):1419-28. PubMed ID: 15809736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclooxygenase-2 expression in human gliomas: prognostic significance and molecular correlations.
    Shono T; Tofilon PJ; Bruner JM; Owolabi O; Lang FF
    Cancer Res; 2001 Jun; 61(11):4375-81. PubMed ID: 11389063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonsteroidal anti-inflammatory drugs suppress glioma via 15-hydroxyprostaglandin dehydrogenase.
    Wakimoto N; Wolf I; Yin D; O'Kelly J; Akagi T; Abramovitz L; Black KL; Tai HH; Koeffler HP
    Cancer Res; 2008 Sep; 68(17):6978-86. PubMed ID: 18757412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Celecoxib and curcumin synergistically inhibit the growth of colorectal cancer cells.
    Lev-Ari S; Strier L; Kazanov D; Madar-Shapiro L; Dvory-Sobol H; Pinchuk I; Marian B; Lichtenberg D; Arber N
    Clin Cancer Res; 2005 Sep; 11(18):6738-44. PubMed ID: 16166455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of cyclooxygenase-2 with NS-398 and the prevention of radiation-induced transformation, micronuclei formation and clonogenic cell death in C3H 10T1/2 cells.
    Bisht KS; Bradbury CM; Zoberi I; Curry HA; Kaushal A; Roti Roti JL; Gius D
    Int J Radiat Biol; 2003 Nov; 79(11):879-88. PubMed ID: 14698956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined effects of radiation and interleukin-13 receptor-targeted cytotoxin on glioblastoma cell lines.
    Kawakami K; Kawakami M; Liu Q; Puri RK
    Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):230-7. PubMed ID: 16111594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nimesulide and indomethacin induce apoptosis in head and neck cancer cells.
    Pelzmann M; Thurnher D; Gedlicka C; Martinek H; Knerer B
    J Oral Pathol Med; 2004 Nov; 33(10):607-13. PubMed ID: 15482327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of cyclooxygenase-2 is associated with radioresistance in oral squamous cell carcinoma.
    Terakado N; Shintani S; Yano J; Chunnan L; Mihara M; Nakashiro K; Hamakawa H
    Oral Oncol; 2004 Apr; 40(4):383-9. PubMed ID: 14969817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of cyclooxygenase-2 activity by celecoxib does not lead to radiosensitization of human prostate cancer cells in vitro.
    Ohneseit PA; Krebiehl G; Dittmann K; Kehlbach R; Rodemann HP
    Radiother Oncol; 2007 Feb; 82(2):229-38. PubMed ID: 17207548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The selective cyclooxygenase-1 inhibitor SC-560 suppresses cell proliferation and induces apoptosis in human hepatocellular carcinoma cells.
    Lampiasi N; Foderà D; D'Alessandro N; Cusimano A; Azzolina A; Tripodo C; Florena AM; Minervini MI; Notarbartolo M; Montalto G; Cervello M
    Int J Mol Med; 2006 Feb; 17(2):245-52. PubMed ID: 16391822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased expression of cyclooxygenase-2 correlates with resistance to radiation in human prostate adenocarcinoma cells.
    Anai S; Tanaka M; Shiverick KT; Kim W; Takada S; Boehlein S; Goodison S; Mizokami A; Rosser CJ
    J Urol; 2007 May; 177(5):1913-7. PubMed ID: 17437847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survivin enhances radiation resistance in primary human glioblastoma cells via caspase-independent mechanisms.
    Chakravarti A; Zhai GG; Zhang M; Malhotra R; Latham DE; Delaney MA; Robe P; Nestler U; Song Q; Loeffler J
    Oncogene; 2004 Sep; 23(45):7494-506. PubMed ID: 15326475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression of cyclooxygenase (COX)-2 in astrocytic tumors and anti-tumor effects of selective COX-2 inhibitors].
    Murakami H; Sawa H; Kamada H
    No To Shinkei; 2006 Jan; 58(1):43-9. PubMed ID: 16482921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteins and protein pattern differences between glioma cell lines and glioblastoma multiforme.
    Vogel TW; Zhuang Z; Li J; Okamoto H; Furuta M; Lee YS; Zeng W; Oldfield EH; Vortmeyer AO; Weil RJ
    Clin Cancer Res; 2005 May; 11(10):3624-32. PubMed ID: 15897557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.